Viewing Study NCT02630602


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-01-15 @ 3:00 AM
Study NCT ID: NCT02630602
Status: COMPLETED
Last Update Posted: 2015-12-15
First Post: 2015-12-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Functional Goat Cheese Effect in Lipid Profile Change
Sponsor: Instituto de Investigación Hospital Universitario La Paz
Organization:

Study Overview

Official Title: Functional Goat Cheese Effect in Lipid Profile Change
Status: COMPLETED
Status Verified Date: 2015-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LODYN
Brief Summary: The purpose this study was to evaluate the therapeutic effect of a functional goat cheese on obese and overweight people with altered lipid profile. The functional goat cheese containing polyunsaturated fatty acid, in amounts exceeding other cheese, was developed to benefit cardiovascular health of people who need to normalize lipid profile; which in the long term can contribute to the prevention of cardiovascular diseases.
Detailed Description: A randomized, parallel, double-blind, controlled is being performing to evaluate the effect of a functional goat cheese on lipid profile in overweight or obese volunteers who need a special diet.

Were included 60 volunteers (men and women) aged between 18 and 65 years (IMC ≥27\<40 Kg/m2) with a cardiovascular risk (\<10%). The volunteers are being followed at La Paz University Hospital of Madrid. For 12 weeks, the volunteers should consume 60 g of cheese daily (functional cheese or control cheese) and to receive advice to follow a balanced and individualized hypocaloric diet as well as physical activity.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: